Key Takeaways
- Through its ARKK and ARKW ETFs, ARK Invest acquired 42,126 Cerebras Systems shares valued at approximately $11.8 million on May 22
- Additional purchases included 105,810 Twist Bioscience shares ($6.2 million) and 25,029 Bullish shares ($900,000)
- The firm divested 1,859 Advanced Micro Devices shares totaling $835,787, extending a multi-day sell-off pattern
- S&P granted Cerebras expedited index inclusion starting May 25, waiving the standard 12-month seasoning requirement
- Revenue concentration presents significant risk: 86% of Cerebras’ income stems from merely two Abu Dhabi-based customers
Cathie Wood’s ARK Invest executed multiple portfolio adjustments on May 22, 2026, with the most significant transaction involving newly public AI semiconductor manufacturer Cerebras Systems.
The investment firm accumulated 42,126 Cerebras shares across its ARKK and ARKW exchange-traded funds, representing an investment of approximately $11.8 million. This acquisition extends ARK’s recent pattern of building a position in the AI chip startup.
Cerebras debuted on public markets May 14 with an initial pricing of $185 per share. The stock surged to $350 at the opening bell and momentarily touched $385 during its inaugural trading session. By week’s end, shares had stabilized around the $280 mark.
The company briefly commanded a market capitalization approaching $100 billion at its trading peak. This valuation appears remarkable considering Cerebras posted $510 million in full-year 2025 revenue and $87.9 million in net income.
Demand for the IPO exceeded available shares by a factor of 20-to-1. Such overwhelming interest suggests investors are prioritizing the company’s technological innovations over near-term financial metrics.
Cerebras’ Technological Edge
Cerebras manufactures processors using an unconventional approach: preserving entire silicon wafers rather than dividing them into individual chips. This creates a singular processing unit approximately dinner-plate-sized. According to the company, this architecture eliminates latency issues associated with connecting multiple conventional processors.
This innovative design has captured significant attention from investors positioning themselves around AI computing infrastructure.
Accelerated S&P Index Entry and Implications
S&P Dow Jones announced May 19 that Cerebras qualified for expedited index inclusion, taking effect May 25. The company secured an exemption from the typical 12-month public trading requirement by satisfying specific market capitalization criteria.
Index membership triggers automatic purchases by passive funds tracking the S&P, generating additional demand following the announcement.
GuruFocus assigns Cerebras a GF Score of 42 out of 100. The company’s financial strength receives a 3 out of 10 rating, acknowledging its early-stage business maturity.
A primary concern among market analysts involves revenue diversification. Just two clients with Abu Dhabi connections generate 86% of total company revenue. Losing either relationship would create substantial challenges in backfilling that income stream.
Public filings show no insider trading activity by company executives during the most recent three-month period.
Additional ARK Portfolio Adjustments
ARK simultaneously acquired 105,810 shares of Twist Bioscience worth $6.2 million, demonstrating sustained conviction in biotechnology investments. The firm also picked up 25,029 Bullish shares distributed across three ETFs, totaling approximately $900,000.
Regarding dispositions, ARK liquidated 1,859 shares of Advanced Micro Devices valued at $835,787 through its ARKW ETF. This sale represents the latest in a week-long series of AMD position reductions.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
